1244 — 3D Medicines Balance Sheet
0.000.00%
Last trade - 00:00- HK$1.61bn
- HK$762.43m
- CNY634.95m
Annual balance sheet for 3D Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 414 | 824 | 942 | 997 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 10.6 | 72.3 | 156 | 5.46 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 462 | 919 | 1,143 | 1,095 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 26.8 | 119 | 178 | 193 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 496 | 1,060 | 1,332 | 1,429 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 315 | 3,248 | 376 | 500 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1,766 | 3,298 | 389 | 492 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Total Equity | -1,270 | -2,238 | 943 | 937 |
| Total Liabilities & Shareholders' Equity | 496 | 1,060 | 1,332 | 1,429 |
| Total Common Shares Outstanding |